Arbutus Biopharma (ABUS) Revenue & Revenue Breakdown

Overview ForecastOwnership Financials Chart

Arbutus Biopharma Revenue Highlights

Latest Revenue (Y)

$14.08M

Latest Revenue (Q)

$179.13M

Main Segment (Y)

License

Arbutus Biopharma Revenue by Period

Arbutus Biopharma Revenue by Year

Date	Revenue	Change
2025-12-31	$14.08M	128.21%
2024-12-31	$6.17M	-65.98%
2023-12-31	$18.14M	-53.51%
2022-12-31	$39.02M	255.11%
2021-12-31	$10.99M	58.92%
2020-12-31	$6.91M	15.02%
2019-12-31	$6.01M	1.88%
2018-12-31	$5.90M	-44.86%
2017-12-31	$10.70M	613.33%
2016-12-31	$1.50M	-93.97%
2015-12-31	$24.87M	65.82%
2014-12-31	$15.00M	-3.00%
2013-12-31	$15.46M	9.05%
2012-12-31	$14.18M	-13.03%
2011-12-31	$16.30M	-23.64%
2010-12-31	$21.35M	54.95%
2009-12-31	$13.78M	42.94%
2008-12-31	$9.64M	-39.46%
2007-12-31	$15.92M	17.05%
2006-12-31	$13.60M	2.36%
2005-12-31	$13.29M	9.21%
2004-12-31	$12.17M	345.43%
2003-12-31	$2.73M	-46.14%
2002-12-31	$5.07M	46.62%
2001-12-31	$3.46M	95.68%
2000-12-31	$1.77M	55.03%
1999-12-31	$1.14M	-7.09%
1998-12-31	$1.23M	-

Arbutus Biopharma generated $14.08M in revenue during NA 2025, up 128.21% compared to the previous quarter, and up 203.69% compared to the same period a year ago.

Arbutus Biopharma Revenue by Quarter

Date	Revenue	Change
2026-03-31	$179.13M	16943.39%
2025-12-31	$1.05M	98.68%
2025-09-30	$529.00K	-95.07%
2025-06-30	$10.74M	508.79%
2025-03-31	$1.76M	12.07%
2024-12-31	$1.57M	17.55%
2024-09-30	$1.34M	-22.42%
2024-06-30	$1.73M	12.66%
2024-03-31	$1.53M	-28.58%
2023-12-31	$2.15M	-53.95%
2023-09-30	$4.66M	0.15%
2023-06-30	$4.65M	-30.45%
2023-03-31	$6.69M	7.08%
2022-12-31	$6.25M	4.92%
2022-09-30	$5.95M	-58.21%
2022-06-30	$14.24M	13.19%
2022-03-31	$12.58M	292.42%
2021-12-31	$3.21M	-4.01%
2021-09-30	$3.34M	43.41%
2021-06-30	$2.33M	10.22%
2021-03-31	$2.11M	-11.44%
2020-12-31	$2.39M	56.66%
2020-09-30	$1.52M	0.59%
2020-06-30	$1.51M	1.54%
2020-03-31	$1.49M	-7.85%
2019-12-31	$1.62M	-47.14%
2019-09-30	$3.06M	368.76%
2019-06-30	$653.00K	-3.83%
2019-03-31	$679.00K	-59.54%
2018-12-31	$1.68M	5.73%
2018-09-30	$1.59M	27.57%
2018-06-30	$1.24M	-13.37%
2018-03-31	$1.44M	-43.33%
2017-12-31	$2.53M	-63.23%
2017-09-30	$6.89M	563.33%
2017-06-30	$1.04M	342.13%
2017-03-31	$235.00K	-220.51%
2016-12-31	$-195.00K	-125.19%
2016-09-30	$774.00K	150.49%
2016-06-30	$309.00K	-48.76%
2016-03-31	$603.00K	-95.25%
2015-12-31	$12.69M	212.08%
2015-09-30	$4.07M	18.17%
2015-06-30	$3.44M	-26.53%
2015-03-31	$4.68M	7.63%
2014-12-31	$4.35M	-0.28%
2014-09-30	$4.36M	140.86%
2014-06-30	$1.81M	-59.12%
2014-03-31	$4.43M	-41.24%
2013-12-31	$7.54M	154.86%
2013-09-30	$2.96M	6.26%
2013-06-30	$2.78M	29.02%
2013-03-31	$2.16M	-43.00%
2012-12-31	$3.79M	22.23%
2012-09-30	$3.10M	-12.99%
2012-06-30	$3.56M	-0.37%
2012-03-31	$3.57M	-7.50%
2011-12-31	$3.86M	-3.68%
2011-09-30	$4.01M	-11.91%
2011-06-30	$4.55M	1.84%
2011-03-31	$4.47M	-32.86%
2010-12-31	$6.66M	-33.84%
2010-09-30	$10.06M	357.85%
2010-06-30	$2.20M	-9.17%
2010-03-31	$2.42M	-46.06%
2009-12-31	$4.48M	46.30%
2009-09-30	$3.07M	-5.79%
2009-06-30	$3.25M	42.63%
2009-03-31	$2.28M	54.99%
2008-12-31	$1.47M	-63.04%
2008-09-30	$3.98M	60.73%
2008-06-30	$2.48M	33.69%
2008-03-31	$1.85M	-56.66%
2007-12-31	$4.28M	-

Arbutus Biopharma generated $179.13M in revenue during Q1 2026, up 16943.39% compared to the previous quarter, and up 11380.30% compared to the same period a year ago.

Arbutus Biopharma Revenue Breakdown

Arbutus Biopharma Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
License	$10.43M	$2.56M	$10.70M	$26.00M	$4.67M
Non-Cash Royalty	$1.48M	$2.25M	$3.87M	$7.65M	$6.11M
Service, Other	$800.00K	-	-	-	-

Arbutus Biopharma's latest annual revenue breakdown by segment (product or service), as of Dec 25: License (82.05%), Non-Cash Royalty (11.65%), and Service, Other (6.29%).

Quarterly Revenue by Product

Product/Service	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21
Non-Cash Royalty	$181.00K	$259.00K	$249.00K	$526.00K	$448.00K	$1.09M	$572.00K	$593.00K	$1.20M	$723.00K	$766.00K	$1.18M	$2.26M	$2.35M	$1.69M	$1.36M	$2.15M	$1.86M	$1.14M	$959.00K
Service, Other	$800.00K	-	$500.00K	$500.00K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
License	$178.74M	-	$9.60M	$9.60M	$800.00K	$1.22M	$644.00K	$695.00K	$400.00K	$3.20M	$3.00M	$4.10M	$2.40M	$11.02M	$9.63M	$992.00K	$55.00K	$22.00K	$59.00K	-
Collaboration And Contracts	-	-	-	-	-	-	-	-	-	-	-	-	$3.98M	-	-	-	-	-	-	-

Arbutus Biopharma's latest quarterly revenue breakdown by segment (product or service), as of Mar 26: License (99.45%), Service, Other (0.45%), and Non-Cash Royalty (0.10%).

Arbutus Biopharma Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
SPRY	ARS Pharmaceuticals	$84.28M	$22.68M
KURA	Kura Oncology	$67.48M	$18.27M
TNGX	Tango Therapeutics	$62.38M	-
SEPN	Septerna	$45.95M	$26.52M
EYPT	EyePoint Pharmaceuticals	$31.37M	$696.00K
NBTX	Nanobiotix	$30.06M	$30.06M
ABUS	Arbutus Biopharma	$14.08M	$179.13M
PROK	ProKidney	$893.00K	$226.00K
SVRA	Savara	-	-
GHRS	GH Research	-	$80.00K
BCAX	Bicara Therapeutics	-	-

ABUS Revenue FAQ

What is Arbutus Biopharma’s yearly revenue?

Arbutus Biopharma's yearly revenue for 2025 was $14.08M, representing an increase of 128.21% compared to 2024. The company's yearly revenue for 2024 was $6.17M, representing a decrease of -65.98% compared to 2023. ABUS's yearly revenue for 2023 was $18.14M, representing a decrease of -53.51% compared to 2022.

What is Arbutus Biopharma’s quarterly revenue?

Arbutus Biopharma's quarterly revenue for Q1 2026 was $179.13M, a 16943.39% increase from the previous quarter (Q4 2025), and a 10054.54% increase year-over-year (Q1 2025). The company's quarterly revenue for Q4 2025 was $1.05M, a 98.68% increase from the previous quarter (Q3 2025), and a -33.23% decrease year-over-year (Q4 2024). ABUS's quarterly revenue for Q3 2025 was $529K, a -95.07% decrease from the previous quarter (Q2 2025), and a -60.49% decrease year-over-year (Q3 2024).

What is Arbutus Biopharma’s revenue growth rate?

Arbutus Biopharma's revenue growth rate for the last 3 years (2023-2025) was -22.37%, and for the last 5 years (2021-2025) was 28.17%.

What are Arbutus Biopharma’s revenue streams?

Arbutus Biopharma's revenue streams in c 25 are License, Non-Cash Royalty, and Service, Other. License generated $10.43M in revenue, accounting 82.05% of the company's total revenue, up 307.26% year-over-year. Non-Cash Royalty generated $1.48M in revenue, accounting 11.65% of the company's total revenue, down -34.19% year-over-year. Service, Other generated $800K in revenue, accounting 6.29% of the company's total revenue

What is Arbutus Biopharma’s main source of revenue?

For the fiscal year ending Dec 25, the largest source of revenue of Arbutus Biopharma was License. This segment made a revenue of $10.43M, representing 82.05% of the company's total revenue.